BioSpace News Archive

BioNTech SE announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing Pte. Ltd. to acquire one of its GMP-certified manufacturing facilities.

A new study from researchers at Hospital for Special Surgery has evaluated trends in the use of total knee arthroplasty in patients under 21 in the United States.

HUTCHMED Limited announces initial results from FRUTIGA, a Phase III study of fruquintinib combined with paclitaxel in 703 Chinese patients with advanced gastric or gastroesophageal junction adenocarcinoma.

SK Biopharmaceuticals announced that the state-run Korea Drug Development Fund has decided to support and finance the company’s development of SKL27969, which is being evaluated as potential treatment for patients with advanced solid tumors, widening SK Biopharmaceuticals’ area into oncology.

Ionis Pharmaceuticals, Inc. presented positive results from a Phase 2 open-label extension study evaluating the safety and efficacy of its investigational antisense medicine, donidalorsen, in patients with hereditary angioedema, a rare and devastating inflammatory disease.

The Lupus Foundation of America is pleased to honor two leading scientists for their notable contributions to lupus research at the 2022 Evelyn V. Hess Reception held during the American College of Rheumatology convergence 2022 meeting this evening in Philadelphia, PA.

Telix Pharmaceuticals Limited announces that it has entered into an agreement with Sacramento-based Northern California PET Imaging Center to acquire Optimal Tracers, a radiochemistry development business providing radiochemistry process development services and research tracers for use in clinical trials.